EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Itaconate: A Potential Therapeutic Strategy for Autoimmune Disease

Yifan Xie iD, Qi Cheng, Meng Li Xu, Jing Xue, Huaxiang Wu, Yan Du

Scandinavian Journal of Immunology · 2025

DOI: 10.1111/sji.70026 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Scandinavian Journal of Immunology, 2025. Verfasst von Yifan Xie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Succinates, Autoimmune Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 139 Literaturangaben. Gefördert von: Natural Science Foundation of Zhejiang Province, National Key Technology Research and Development Program of China, Zhejiang Provincial Administration of Traditional Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Itaconate is a metabolite of the Krebs cycle, and endogenous itaconate is driven by a variety of innate signals that inhibit the production of inflammatory cytokines. The key mechanism of action of itaconate was initially found to be the competitive inhibition of succinate dehydrogenase (SDH), which inhibits the production of inflammatory factors, as well as its antioxidant effects. With increasing research, it was discovered that it modifies cysteine residues of related proteins through the Michael addition, such as modifying the Kelch‐like ECH‐associated protein 1 (KEAP1) protein and activating the nuclear factor erythroid 2‐related factor 2 (NRF2) signalling pathway, as well as glycolytic enzymes and cellular pathway‐associated factors that attenuate inflammatory responses and oxidative stress. It also acts on a variety of immune cells, affecting their function and activity, and has been increasingly shown to play a therapeutic role in a variety of inflammatory and autoimmune diseases through a combination of these mechanisms. In conclusion, there has been a great breakthrough in the research of itaconate, from the initial industrial application to the redefinition of the biological functions of itaconate. However, with the deepening of the research, we also found that there are more questions: the mechanism of action of itaconate, more functions of itaconate, clinical application of itaconate, and the use of itaconate still needs to be solved.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SuccinatesAutoimmune DiseasesHumansAnimalsSignal TransductionOxidative StressNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1InflammationAntioxidantsSuccinate DehydrogenaseCytokines

Stichwörter der Autor:innen

autoimmunediseasesimmune cellsitaconatetherapy

Substanzen

Succinatesitaconic acidNF-E2-Related Factor 2Kelch-Like ECH-Associated Protein 1AntioxidantsSuccinate DehydrogenaseCytokines

Autor:innen und Institutionen

  • Department of Rheumatology, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Clinic Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Nephrology, The Third Affiliate Hospital of Zhejiang Chinese Medical University, Hangzhou, China.

ORCID-Profile: Yifan Xie

Förderung

  • Natural Science Foundation of Zhejiang Province
  • National Key Technology Research and Development Program of China
  • Zhejiang Provincial Administration of Traditional Chinese Medicine
  • Zhejiang Traditional Chinese Medicine Administration

Zitieren

APA

Xie, Y., Cheng, Q., Xu, M. L., Xue, J., Wu, H., & Du, Y. (2025). Itaconate: A Potential Therapeutic Strategy for Autoimmune Disease. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.70026

Vancouver

Xie Y, Cheng Q, Xu ML, Xue J, Wu H, Du Y. Itaconate: A Potential Therapeutic Strategy for Autoimmune Disease. Scandinavian Journal of Immunology. 2025. doi:10.1111/sji.70026

BibTeX
@article{Xie2025,
  author = {Xie, Yifan and Cheng, Qi and Xu, Meng Li and Xue, Jing and Wu, Huaxiang and Du, Yan},
  title = {Itaconate: A Potential Therapeutic Strategy for Autoimmune Disease},
  journal = {Scandinavian Journal of Immunology},
  year = {2025},
  doi = {10.1111/sji.70026}
}
Kostenlos starten →